Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr David Sheridan

Newcastle AuthorsTitleYearFull text
Dr Simon Bridge
Dr David Sheridan
Dr R Neely
Emeritus Professor Margaret Bassendine
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?2025
Dr David Sheridan
Professor Stuart McPherson
National study of NAFLD management identifies variation in delivery of care in the UK between 2019-20222023
Professor David Jones
Dr David Sheridan
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis2022
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Emeritus Professor Margaret Bassendine
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis2022
Dr David Sheridan
Professor Quentin Anstee
Professor Stuart McPherson
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey2017
Emeritus Professor Margaret Bassendine
Dr Soren Nielsen
Dr Simon Bridge
Dr Daniel Felmlee
Dr David Sheridan
et al.		Hepatitis C virus and atherosclerosis: A legacy after virologic cure?2017
Dr Luca Miele
Dr David Sheridan
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes2016
Dr David Sheridan
FibroGENE: A gene-based model for staging liver fibrosis2016
Dr David Sheridan
Fiona Fenwick
Emeritus Professor Margaret Bassendine
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection2016
Professor Quentin Anstee
Dr David Sheridan
Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study2016
Dr David Sheridan
Professor Margaret Bassendine
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Emeritus Professor Margaret Bassendine
Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection2015
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Fiona Fenwick
Dr Clare Lanyon
et al.		PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Emeritus Professor Margaret Bassendine
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency2014
Dr David Sheridan
Emeritus Professor Margaret Bassendine
Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection2014
123